Literature DB >> 21992245

Spinal cord stimulation for Raynaud's syndrome: long-term alleviation of bilateral pain with a single cervical lead.

Tilman Wolter1, Kristin Kieselbach.   

Abstract

INTRODUCTION: Spinal cord stimulation (SCS) has been described in a variety of neuropathic and vasospastic pain conditions including Raynaud's syndrome.
METHODS: We report here the outcome of single lead SCS in the case of a 49-year-old woman with severe Raynaud's syndrome, which had failed to respond to medical therapy.
RESULTS: With a single quadripolar cervical lead in midline position at the C2/C3 level sustained pain relief of the bilateral pain was accomplished. Pain scores sank from 7/10 to 2-3/10 on the nominal analog scale and remained stable more than nearly four years by now.
CONCLUSIONS: Treatment of bilateral pain in Raynaud's syndrome with SCS in a single technique is feasible. Advantages and disadvantages as compared with stimulation with bilateral leads are discussed.
© 2011 International Neuromodulation Society.

Entities:  

Mesh:

Year:  2011        PMID: 21992245     DOI: 10.1111/j.1525-1403.2011.00332.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  4 in total

1.  Spinal cord stimulation reduces mechanical hyperalgesia and glial cell activation in animals with neuropathic pain.

Authors:  Karina L Sato; Lisa M Johanek; Luciana S Sanada; Kathleen A Sluka
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

2.  Dorsal column stimulator applications.

Authors:  Claudio Yampolsky; Santiago Hem; Damián Bendersky
Journal:  Surg Neurol Int       Date:  2012-10-31

3.  Spinal cord stimulation: panacea for incurable diseases?

Authors:  Jae Hang Shim
Journal:  Korean J Anesthesiol       Date:  2013-08

4.  Successful Spinal Cord Stimulation for Necrotizing Raynaud's Phenomenon in COVID-19 Affected Patient: The Nightmare Comes Back.

Authors:  Mariateresa Giglio; Angela Preziosa; Martina Rekatsina; Omar Viswanath; Ivan Urits; Giustino Varrassi; Antonella Paladini; Filomena Puntillo
Journal:  Cureus       Date:  2021-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.